10 Most Overbought S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

As of date:2/20/2020
INCY stock price:82.77
INCY RSI:83.51
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)83.51
Extremely
Oversold

Also see:
INCY Market Cap History
INCY Shares Outstanding History
INCY YTD Return
INCY DMA
INCY MACD
INCY Technical Analysis

BMRC Makes Notable Cross Below Critical Moving Average
1 hour, 2 minutes ago


Notable Two Hundred Day Moving Average Cross - WTBA
1 hour, 2 minutes ago


EDIT Crosses Below Key Moving Average Level
1 hour, 2 minutes ago


Notable Two Hundred Day Moving Average Cross - ALTR
1 hour, 2 minutes ago


WDAY Crosses Below Key Moving Average Level
1 hour, 2 minutes ago


IPLDP Crosses Below Key Moving Average Level
1 hour, 2 minutes ago


Notable Two Hundred Day Moving Average Cross - BATRA
1 hour, 3 minutes ago


HLX Makes Notable Cross Below Critical Moving Average
1 hour, 34 minutes ago


Independence Holding Breaks Below 200-Day Moving Average - Notable for IHC
1 hour, 51 minutes ago


Urstadt Biddle Properties Breaks Above 200-Day Moving Average - Bullish for UBA
1 hour, 51 minutes ago


Public Service Enterprise Group Breaks Above 200-Day Moving Average - Bullish for PEG
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - MLM
1 hour, 56 minutes ago


HYS Shares Cross Below 200 DMA
1 hour, 56 minutes ago


Novo Resources (NVO.CA) Shares Cross Below 200 DMA
1 hour, 56 minutes ago


FLJP Crowded With Sellers
1 hour, 56 minutes ago


More Technical Analysis News

INCY RSIINCY DMA
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. JAKAFI (ruxolitinib) has been approved for the treatment of patients with intermediate or high-risk myelofibrosis, for the treatment of patients with polycythemia vera, and for the treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older. Co. has also obtained a license to develop and commercialize ICLUSIG (ponatinib) in Europe and other select countries. In the European Union, ICLUSIG is approved for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia.

When researching a stock like INCY, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from INCY Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for INCY stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of these ways is called the Relative Strength Index, or RSI. This popular indicator, originally developed in the 1970's by J. Welles Wilder, looks at a 14-day moving average of a stock's gains on its up days, versus its losses on its down days. The resulting INCY RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. A reading above 70 is viewed to be overbought, which could indicate that a rally in progress is starting to get crowded with buyers. If the rally has been a long one, that could be a sign that a pullback is overdue.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for INCY:
INCY SEC Filing Email Alerts ServiceExternal link
Video: RSI Indicator


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
INCY (INCY) is categorized under the Healthcare sector; to help you further research RSI, below are some other companies in the same sector:

IQV RSI
ISRG RSI
JNJ RSI
LH RSI
LLY RSI
MCK RSI
MDT RSI
MMM RSI
MRK RSI
MYL RSI
More Healthcare companies »

 

10 Most Overbought S&P 500 Stocks | Page 1 of 10 | www.StockRSI.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockRSI.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.